New Biologic is 'Potential Blockbuster' for Eczema Treatment

Dupilumab safely and effectively controls the symptoms of moderate to severe eczema over the long-term, 1-year data show. FDA approval of the biologic is expected soon, the lead investigator reports.
Medscape Medical News

http://ift.tt/2mcx1tL